This investment comes after news of the Trump administration abruptly canceling hundreds of federal grants nationwide that support substance abuse treatment.

According to the settlement administrators, most eligible class members who submit a qualifying claim can receive approximately $11,000.

EBSA said the $1.4 billion returned to plans, participants and beneficiaries represents a slight increase from the $1.384 billion recovered in fiscal year 2024.

Although it was expected to go live in late January, HHS Secretary Robert F. Kennedy Jr. announced at a cabinet meeting last week that it instead "is going to be happening sometime, probably in the ...

U.S. District Judge Brian Martinotti recently issued two rulings that let pharmacies, or "direct purchaser" plaintiffs, move ahead with claims against pharmacy benefit managers that were based on the ...

The employer PBM provisions: One employer PBM transparency provision in the CAA 2026 package calls for PBMs to send employer health plan fiduciaries detailed prescription benefits operations data. The ...

Late last week, the U.S. Department of Labor (DOL) filed an amicus brief urging the Third Circuit to uphold a lower court's dismissal in Barragan v. Honeywell Int'l Inc.

The average allowed amount for a patient with no chronic conditions was $1,590, while the average allowed amount for a patient with one chronic condition was nearly double, at $3,039.

The former employees argue that the company was involved in self-dealing and prohibited transactions under ERISA because it designed its own funds, picked the managers, decided how assets were ...

"Without real-time supply-chain visibility, teams are forced to make critical decisions with incomplete information." said Jeff Wagner vice president of pharmacy, respiratory care and ECMO services ...

West Virginia began to license PBMs in 2020. In 2022, the state began to require insurers to pass all prescription drug rebates and other prescription drug discounts on to health insurance purchasers ...

The complaint, filed by the law firm Sanford Heisler Sharp McKnight, alleges that Bloomberg failed to remove two funds from its plan after they performed poorly for more than a decade.